Clinical Protocol Design
Optimize inclusion and exclusion criteria, endpoint selection, and dosing regimens by benchmarking against the global trial designs of competing therapies, strengthening protocol design and competitive positioning.
As global clinical development becomes increasingly competitive, deep understanding of the clinical trial landscape and study design strategies of competing therapies is essential for an optimal R&D strategy. Drawing on data from six major global clinical trial registries, the Clinical R&D Insights solution provides deep visibility into global trial activity and protocol designs, helping teams optimize clinical development strategies and trial execution.
Optimize inclusion and exclusion criteria, endpoint selection, and dosing regimens by benchmarking against the global trial designs of competing therapies, strengthening protocol design and competitive positioning.
Gain real-time visibility into competitors' clinical development progress across regions to plan trial timelines effectively and maintain a competitive path to regulatory submission.
Analyze the global clinical development strategies of comparable therapies to inform differentiated regulatory strategies and optimize regional clinical development planning.
GBI aggregates data from six major global clinical trial registries, transforming fragmented, unstructured trial information into structured, searchable, and comparable clinical intelligence. By reducing the need for time-consuming manual literature reviews, the platform enables R&D teams to focus on higher-value clinical strategy and decision-making.
GBI integrates data from six major global clinical trial registries, including CDE Clinical Trials, ClinicalTrials.gov, ChiCTR, HGRAC (Human Genetic Resources Administration of China), Japan jRCT, and WHO ICTRP. By cross-linking data across registries for the same trial, the platform covers over 1.1 million clinical trials with daily updates for actionable, real-time intelligence.
Each trial record integrates key information from multiple clinical trial registries, including treatment and control arms, trial status, and clinical development timelines. Users can filter data by drug name, indication, target, study phase, region, and other criteria to quickly identify relevant studies and assess the clinical development landscape for competing therapies.
Gain deep insights into the clinical trial design strategies of competing therapies across key dimensions, including endpoint selection, comparator choice, inclusion and exclusion criteria, sample size, study design across Phases I–III, and country-specific development strategies. These insights help R&D teams identify prevailing design trends and opportunities for differentiation, supporting more informed clinical trial design and protocol optimization.
GBI Health unites global pharmaceutical data, AI capabilities and industry expertise to deliver future-ready solutions across the entire product lifecycle.
Contact Us